US Bancorp
XBIT icon

US Bancorp’s XBiotech XBIT Stock Holding History

US Bancorp’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-100
Closed -$395 – 4376
2024
Q4 		$395 Hold
100
– – ﹤0.01% 4041
2024
Q3 		$773 Hold
100
– – ﹤0.01% 3919
2024
Q2 		$514 Buy
+100
New +$771 ﹤0.01% 3859
2021
Q4 		– Sell
-450
Closed -$6K – 4247
2021
Q3 		$6K Hold
450
– – ﹤0.01% 3609
2021
Q2 		$7K Sell
450
-70
-13% -$1.19K ﹤0.01% 3537
2021
Q1 		$9K Hold
520
– – ﹤0.01% 3343
2020
Q4 		$8K Hold
520
– – ﹤0.01% 3276
2020
Q3 		$10K Sell
520
-1,220
-70% -$21.1K ﹤0.01% 3093
2020
Q2 		$24K Buy
+1,740
New +$24.5K ﹤0.01% 2743

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

US Bancorp's XBIT Position: Q1 2025 in Review

US Bancorp sold out of XBiotech (XBIT) in Q1 2025, closing a stake of 100 shares — an estimated $395 sold.

US Bancorp first reported a position in XBIT in Q2 2020 and held it in 9 quarters. The position peaked at $24K in Q2 2020. 55 funds tracked by Wall St. Rank hold XBIT as of Q1 2025.

  • US Bancorp reported no remaining XBiotech position as of Q1 2025 after selling out during the quarter.
  • US Bancorp sold 100 XBiotech shares in Q1 2025, an estimated $395.
  • US Bancorp first reported a position in XBiotech in Q2 2020 and held it in 9 quarters.
  • US Bancorp's XBiotech position peaked at $24K in Q2 2020.
  • 55 funds tracked by Wall St. Rank held XBiotech as of Q1 2025.

Based on US Bancorp's 13F filing for Q1 2025, filed 8 May 2025.